All Stories

  1. Altered cholesterol immunometabolism activates the macrophage NLRP3-inflammasome in lung fibrosis
  2. Thermodynamic Insights into Native Pulmonary Surfactant Films: Elastic Compression Modulus and Energy Dissipation under Cyclic Deformation
  3. Cholesterol-mediated inflammation activation in alveolar macrophages
  4. Mechanical strain exacerbates Pseudomonas infection in an organoid-based pneumonia-on-a-chip model
  5. Neutrophil-chemoattractant CXCL5 increases lung barrier permeability in acute lung injury
  6. Cell Surface RNA Expression Modulates Alveolar Epithelial Function
  7. Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility to Streptococcus pneumoniae
  8. Comparative electron microscopic visualization of the lung alveolar epithelial glycocalyx with different staining and labeling methods
  9. Characterization of Commercially Available Human Primary Alveolar Epithelial Cells
  10. Multivalent, calcium-independent binding of surfactant protein A and D to sulfated glycosaminoglycans of the alveolar epithelial glycocalyx
  11. Enzymatic modulation of the pulmonary glycocalyx alters susceptibility toStreptococcus pneumoniae
  12. The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment
  13. Ten simple rules for implementing open and reproducible research practices after attending a training course
  14. Resting time after phorbol 12-myristate 13-acetate in THP-1 derived macrophages provides a non-biased model for the study of NLRP3 inflammasome
  15. Human alveolar progenitors generate dual lineage bronchioalveolar organoids
  16. The ultrastructural heterogeneity of lung surfactant revealed by serial section electron tomography: insights into the 3-D architecture of human tubular myelin
  17. Rescue from Pseudomonas aeruginosa Airway Infection via Stem Cell Transplantation
  18. Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis
  19. Metabolic Glycoengineering Enables the Ultrastructural Visualization of Sialic Acids in the Glycocalyx of the Alveolar Epithelial Cell Line hAELVi
  20. Mechanical ventilation-induced alterations of intracellular surfactant pool and blood–gas barrier in healthy and pre-injured lungs
  21. Pulmonary glycogen deficiency as a new potential cause of respiratory distress syndrome
  22. Hidden Microatelectases Increase Vulnerability to Ventilation-Induced Lung Injury
  23. Corrigendum: Alveolar Dynamics and Beyond – the Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis
  24. Reply to: Comments on “Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C”
  25. Spermidine supplementation and voluntary activity differentially affect obesity-related structural changes in the mouse lung
  26. Alveolar Dynamics and Beyond – The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis
  27. On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx
  28. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition
  29. Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C
  30. Surfactant Protein B Deficiency Induced High Surface Tension: Relationship between Alveolar Micromechanics, Alveolar Fluid Properties and Alveolar Epithelial Cell Injury
  31. Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis
  32. Flow cytometric analysis of the leukocyte landscape during bleomycin-induced lung injury and fibrosis in the rat
  33. Voluntary Activity Modulates Sugar-Induced Elastic Fiber Remodeling in the Alveolar Region of the Mouse Lung
  34. The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis
  35. Voluntary Activity Modulates Sugar-Induced Mechanical and Structural Changes of the Lung
  36. Protein and lipid fingerprinting of native-like membrane complexes by combining TLC and protein electrophoresis
  37. Surfactant dysfunction and alveolar collapse are linked with fibrotic septal wall remodeling in the TGF-β1-induced mouse model of pulmonary fibrosis
  38. How alveoli (small balloon-like air spaces) behave during lung injury
  39. An immune cell spray (ICS) formulation allows for the delivery of functional monocyte/macrophages
  40. Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
  41. iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice
  42. Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model
  43. Aging exacerbates acute lung injury-induced changes of the air-blood barrier, lung function, and inflammation in the mouse
  44. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF
  45. Lung surfactant metabolism: early in life, early in disease and target in cell therapy
  46. Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films
  47. Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo
  48. Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model
  49. Alveolar Derecruitment and Collapse Induration as Crucial Mechanisms in Lung Injury and Fibrosis
  50. Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy
  51. Transient Exposure of Pulmonary Surfactant to Hyaluronan Promotes Structural and Compositional Transformations into a Highly Active State
  52. Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants
  53. Interfacial behavior and structural properties of a clinical lung surfactant from porcine source
  54. Exposure to Polymers Reverses Inhibition of Pulmonary Surfactant by Serum, Meconium, or Cholesterol in the Captive Bubble Surfactometer
  55. Meconium Impairs Pulmonary Surfactant by a Combined Action of Cholesterol and Bile Acids